Alessandro Agosti

Our Indian site successfully inspected by TGA

Proud to share that our Indian site has been inspected by the Australian authority (TGA) from 15th to 22nd December 2...
Alessandro Agosti

A division specialising in microbial fermentation technologies

Olon presents Olon Biotech, new division operating by biotechnological processes  
Alessandro Agosti

Olon meets Unito

8th of July, - Olon Group has been guest of the University of Turin to discuss with top management and researchers ho...
Alessandro Agosti

Olon announces the creation of a major center of research and development in Italy

The Centre will give rise to an innovative global R&D model

Events 2023

In the coming months we will be present at these sector events. The list is constantly updated and may be subject to changes.


Regulatory inspections

Our facilities are regularly inspected by the most important national and foreign medicine agencies: FDA - Food and Drug Administration (USA), AIFA - Agenzia Italiana del Farmaco (Italy), AEMPS - Agencia Espanola de Medicamentos y productos sanitarios (Spain), Russian Health Authority, PEBC - Pharmacy Examining Board of Canada, COFEPRIS - Comisión Federal para la Protección contra Riesgos Sanitarios (Mexico), TGA - Therapeutic Goods Administration (Australia), PDMA - Pharmaceuticals and Medical Devices Agency (Japan), KFDA - Ministry of Food and Drug Safety (Korea), ANVISA - Agency Nacional de Vigilancia Sanitária (Brazil), WHO - World Health Organization.

2022 Rodano
2023 Settimo
2023 Garbagnate
2023 Mulazzano
2023 Dorno
2023 Segrate
2022 Casaletto
2022 Capua
2023 Derivados Quimicos
2019 Ricerca Bioscience
2022 Olon India